About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 11–20 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 11 |
NATURE REVIEWS CANCER NAT REV CANCER |
1474-175X 1474-1768 |
66.8 | 81 | Q1 | 3/326 | NATURE PORTFOLIO |
| 12 |
World Psychiatry WORLD PSYCHIATRY |
1723-8617 2051-5545 |
65.8 | 60 | Q1 | 1/288 | WILEY |
| 13 |
ANNALS OF ONCOLOGY ANN ONCOL |
0923-7534 1569-8041 |
65.4 | 46.8 | Q1 | 4/326 | ELSEVIER |
| 14 |
Living Reviews in Relativity LIVING REV RELATIV |
2367-3613 1433-8351 |
62.5 | 52.4 | Q1 | 31-Jan | SPRINGER INT PUBL AG |
| 15 |
NATURE REVIEWS IMMUNOLOGY NAT REV IMMUNOL |
1474-1733 1474-1741 |
60.9 | 77.6 | Q1 | 1/183 | NATURE PORTFOLIO |
| 16 |
Nature Reviews Disease Primers NAT REV DIS PRIMERS |
2056-676X 2056-676X |
60.6 | 104.8 | Q1 | 3/332 | NATURE PORTFOLIO |
| 17 |
MMWR Recommendations and Reports MMWR RECOMM REP |
1057-5987 1545-8601 |
60.1 | 50 | Q1 | 1/419 | CENTERS DISEASE CONTROL & PREVENTION |
| 17 |
Nature Energy NAT ENERGY |
2058-7546 2058-7546 |
60.1 | 68.9 | Q1 | 2/460 | NATURE PORTFOLIO |
| 19 |
Nature Reviews Methods Primers NAT REV METHOD PRIME |
N/A 2662-8449 |
56 | 66.9 | Q1 | 1/135 | SPRINGERNATURE |
| 20 |
CHEMICAL REVIEWS CHEM REV |
0009-2665 1520-6890 |
55.8 | 67.5 | Q1 | 1/239 | AMER CHEMICAL SOC |